Neuren Pharmaceuticals | NEU - Ordinary Share Capital

Stock Price
12.71
Daily Change
0.47 3.84%
Monthly
-26.74%
Yearly
-2.53%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD165.27M in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Genetic Signatures AUD 127.64M 8.22M Dec/2024
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Organon & Co USD 259.98M 18K Sep/2025
Paradigm Biopharmaceuticals AUD 253.24M 15.12M Dec/2024
PYC Therapeutics AUD 230.58M 0 Dec/2024
Starpharma Holdings AUD 240.75M 0 Dec/2024
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025